Skip to main content

Editas Medicine, Inc 10-Q for FY2023 Q2

Editas Medicine, Inc. (EDIT)

10-Q 2023-08-02 For: 2023-06-30
View Original
Added on April 10, 2026

About this 10-Q

Editas Medicine, Inc filed this 10-Q on August 2, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).

Headline figures

Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$2.89M
down 54.6% from $6.36M a year earlier
Net loss
$40.29M
compared with a net loss of $53.45M a year earlier
Diluted EPS
-$0.56
compared with -$0.78 a year earlier